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Three sets of electrodiagnostic criteria for establishing primary demyelina- 
tion in chronic polyneuropathy are evaluated. Sensitivity is assessed in 70 
patients with clinically established chronic inflammatory demyelinating poly- 
radiculoneuropathy (CIDP). The criteria use different abnormal values, one 
adjusts for the effects of axonal loss, while another relies only on conduc- 
tion velocity. However, even when consideration is given to sufficient num- 
ber of nerves tested, there is no significant difference (P  = 0.37) in diag- 
nostic sensitivity among them, with 48% to 64% of CIDP patients fulfilling 
criteria for primary demyelination. Specificity is assessed by applying the 
criteria to 47 patients with motor neuron disease and 63 patients with dia- 
betic polyneuropathy. No patients meet any of the criteria. Further analysis 
shows that as sensitivity increases specificity decreases, because of over- 
lapping distributions of nerve conduction abnormalities in these neuropathic 
disorders. A sensitivity of approximately 66% is a practical limit for elec- 
trodiagnostic criteria in CIDP. 
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COMPARISON OF ELECTRODIAGNOSTIC 
CRITERIA FOR PRIMARY 
DEMYELINATION IN CHRONIC 
POLYNEUROPATHY 
MARK B. BROMBERG, MD, PhD 
T h e  diagnosis of chronic inflammatory demyeli- 
nating polyradiculoneuropathy (CIDP) is made 
from the clinical history, physical examination, 
and laboratory tests. l 1  Measurement of nerve con- 
duction is helpful because it permits electrodiag- 
nostic assessment of demyelination, the primary 
underlying pathology. 11p20 Expected changes are 
slowed conduction velocity, abnormal temporal 
dispersion, and conduction block. l4 The wide 
range of normal values for these measures make it 
important to establish abnormal values which are 
reasonably predictive of primary demyelination. 
In early studies of CIDP, slowed motor nerve con- 
duction velocity and subjective estimates of abnor- 
mal temporal dispersion were empha~ized.~. '  1*16220 
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In later studies, formal sets of criteria were pro- 
posed to establish electrodiagnostic evidence of 
primary demyelination which consider distal la- 
tency, conduction velocity, partial conduction 
block or abnormal temporal dispersion, and 
F-wave latency. 
Three sets of criteria have been recently pro- 
posed for electrodiagnostic identification of pa- 
tients with CIDP.1,334 They differ in several re- 
spects; they use different values to define 
abnormalities, 1 attempts to account for the effect 
of axonal loss on nerve conduction, while another 
considers only conduction velocity (Table 1).  The 
sensitivity of these criteria for identifying CIDP 
has not been evaluated in a large group of pa- 
tients, nor have the criteria been compared with 
each other. Furthermore, specificity (true negative 
rate) in identifying primary demyelination has not 
been established in groups of patients with neuro- 
pathic disorders in which demyelination is unex- 
pected or is considered to be of secondary impor- 
tance to axonal damage.6 
In this report, three sets of criteria are evalu- 
ated for sensitivity using nerve conduction data 
from patients with the clinical diagnosis of CIDP. 
Specificity is tested on nerve conduction data from 
patients with motor neuron disease (MND) and di- 
abetic polyneuropathy (DP). Factors in the mea- 
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Table 1. Proposed electrodiagnostic criteria for primary demyelination in CIDP. 
Set A3 
Must demonstrate 3 of the following abnormalities in motor nerves. 
1. Reduced conduction velocity in 2 or more nerves: 
2. Partial conduction block or abnormal temporal dispersion in 1 or more nerves: 
3. Prolonged distal latency in 2 or more nerves: 
4. Prolonged F-wave latency in 1 or more nerves: 
Modified A 
Same as above, except that reduction in conduction velocity and prolonged distal latency need be present in only 1 nerve to be 
counted as 1 of the 3 abnormalities. 
Set B' 
Must demonstrate 3 of the following abnormalities in motor nerves. 
1. Reduction in conduction velocity in 2 or more nerves: 
~ 8 0 %  of LLN if CMAP amplitude >80% of LLN, or 
<70% of LLN if CMAP amplitude <80% of LLN. 
a. partial conduction block: 
<8O% P/D ratio if duration of negative peak of proximal CMAP is <115% of distal CMAP duration. 
b. abnormal temporal dispersion and possible conduction block: 
<80% P/D ratio if duration of negative peak of proximal CMAP is >115% of distal CMAP duration. 
>125% of ULN if CMAP amplitude >80% of LLN, or 
>150% of ULN if CMAP amplitude ~ 8 0 %  of LLN. 
>120% of ULN if CMAP amplitude is >80% LLN, or 
>150% of ULN if CMAP amplitude is <80% LLN, or absent F wave after 10 to 15 trials. 
<75% of LLN.' 
<70% P/D rati0.t 
>130% of ULN.* 
>130% of ULN. 
2. Partial conduction block or abnormal temporal dispersion in 1 or more nerves (median, ulnar, peroneal): 
3. Prolonged distal latency in 2 or more nerves: 
4. Prolonged F-wave latency in 2 or more nerves: 
Set 63 
Must demonstrate the following abnormality in motor nerves. 
1. Reduction in conduction velocity in 2 or more nerves: 
Modified C 
Same as above, except that reduction in conduction velocity need be present in only 1 nerve to fulfill criteria. 
<70% of LLN. 
'LLN: lower limit of normal. 
jPID: proximal to distal compound muscle action potential (CMAP) amplitude ratio 
#ULN: upper limit of normal. 
surement of nerve conduction which influence 
sensitivity are identified, and evidence is pre- 
sented for an upper limit of sensitivity which pre- 
serves reasonable specificity. 
METHODS 
Nerve conduction data were obtained from 3 
groups of patients. (a) Seventy patients, who were 
actively followed in our clinic, fulfilled clinical cri- 
teria for idiopathic CIDP. l 1  Criteria included pro- 
gressive, relapsing or stepwise course with weak- 
ness and sensory disturbance, cerebrospinal fluid 
cytoalbuminic dissociation in most patients, re- 
sponse to corticosteroids and therapeutic plasma 
exchange, and exclusion of other diagnoses, such 
as associated monoclonal gammopathy, l 3  multifo- 
cal conduction block n e ~ r o p a t h y , ' ~  or systemic 
dysimmune disorders. (b) Forty-seven patients, 
who were actively followed in our clinic, fulfilled 
criteria for MND. l8 These included clinical evi- 
dence for upper motor neuron loss, electrodiag- 
nostic evidence for lower motor neuron loss in at 
least 3 extremities, and exclusion of other diag- 
noses. Data reviewed for patients with CIDP and 
MND were obtained at the time of their initial 
evaluation. (c) Sixty-three patients, referred to the 
EMG Laboratory, had insulin-dependent or non- 
insulin-dependent diabetes mellitus and clinically 
evident polyneuropathy of mild-to-moderate se- 
verity. This group represented consecutive, unse- 
lected patients referred for confirmation of the 
polyneuropathy . 
Nerve conduction studies were performed us- 
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FIGURE 1. Distribution of values for motor nerve conduction measures. Values for upper extremity nerve displayed in left scattergrams, 
values for lower extremity in right scattergrams. Horizontal lines at left hand side mark upper and lower limits of normal values (ULN and 
LLN, respectively). Horizontal lines to right of scattergrams mark values for 75th percentile for patients with ClDP (true positive) and 
percentile values (false positive) for patients with diabetic polyneuropathy (DP) and motor neuron disease (MND). Dashed lines with 
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ing conventional techniques.2 These included re- 
cording of the compound muscle action potential 
(CMAP) with surface disc electrodes. Proximal 
stimulation sites for the ulnar and peroneal nerves 
were below the elbow and fibular head, respec- 
tively. Skin temperature was maintained between 
32” and 34°C with hot packs. When bilateral mea- 
surements were made on specific nerves, only 
measures from one side of the body were analyzed 
(the side with the greatest number of nerve stud- 
ied). 
Nerve conduction values were reviewed to de- 
termine if they exceeded abnormal limits listed in 
Table 1 for 3 sets of criteria, designated sets A3, 
B’, and C4. A modification was made to the sec- 
ond criterion of set B. Because duration measure- 
ments of the negative component of the CMAP 
were not available for every patient, no distinction 
was made between partial conduction block and 
abnormal temporal dispersion with possible con- 
duction block; the term “conduction blocklabnor- 
ma1 temporal dispersion” used in this report re- 
fers to measurements in which the proximal : distal 
CMAP ratio was lower than the limiting values 
listed in criteria sets A and B. 
The number of abnormal nerve conduction 
values for each patient was tabulated to determine 
if the patient completely fulfilled requirements for 
primary demyelination. Abnormal values for indi- 
vidual measures were calculated as percentages of 
laboratory upper limits of normal (ULN) or lower 
limits of normal (LLN) values. The limits of nor- 
mal were set at the range for values not normally 
distributed (tibia1 motor nerve distal latency and 
conduction velocity) or at 2 SD above or below 
normal mean values for normally distributed mea- 
sures. The normal laboratory values were ob- 
tained from subjects of both genders, and whose 
ages ranged from the first to the seventh decades. 
The ULN and LLN are marked in Figure 1. 
Chi-square tests for differences in proportions 
Table 2. Demographic features of 3 groups of patients. 
Motor 
neuron Diabetic 
CIDP disease polyneuropathy 
Gender: 
Men 41 (59%) 26 (55%) 28 (44%) 
Women 29 (41%) 21 (45%) 35 (56%) 
Age at time of study: 
Mean (years) 48 62 55 
Range (years) 4-76 19-82 22-84 
were performed. Because of multiple compari- 
sons, P-values less than .01 are considered statisti- 
cally significant, P-values between .01 and .05 
marginally significant, and P-values greater than 
.05 not significant. 
RESULTS 
The age and gender distributions (Table 2) are 
similar to those reported for CIDP and MND pa- 
t ient~.~”’  
Sensitivity of Criteria A, B, and C for CIDP. Sensitiv- 
ities (true positive rate) of each of the 3 criteria 
were determined using available nerve conduction 
data for each patient. Sets A, B, and C had sensi- 
tivities of 5076, 46%, and 43%, respectively, and 
differences in these rates were not statistically sig- 
nificant (P = 59)  (Table 3). Not every testable mo- 
tor nerve was evaluated in each patient so that 
failure to fulfill a set could possibly result from in- 
sufficient sampling. Exclusion of such patients and 
recalculation of sensitivity resulted in 64% of pa- 
tients fulfilling criteria for set A, 60% for set B, 
and 48% for set C. The difference in proportions 
were not statistically significant (P  = .37). The ap- 
parent increase in sensitivity may be an overesti- 
mate because not every untested nerve would be 
abnormal. 
Comparison of the 3 Criteria. The three criteria 
differ from each other by using different abnor- 
mal values for individual measures of nerve con- 
duction and by requiring different numbers of ab- 
normal measures to meet full criteria (Table 1). 
The sensitivity of each set was studied by review- 
ing the data to determine (a) which individual 
nerve conduction measure was most frequently 
abnormal, and (b) which measure was most often 
abnormal in the required number of nerves (Ta- 
ble 4). For example, when the abnormal level for 
conduction velocity was 75% of the LLN, as in set 
A (Table l), significantly more (P = .0001) indi- 
vidual nerves were abnormal than when the level 
was 70% of the LLN as in set C (Table 4). Similar 
findings were noted for F-wave latency, and sig- 
nificantly more (P = .0001) nerves were abnormal 
in set B (120% of ULN) compared with A (130% 
of ULN). In set B, F-wave latency was most fre- 
quently judged abnormal at 120% of the ULN be- 
cause most nerves had a CMAP amplitude greater 
than 80% of the LLN (Table 1). 
When the data were reviewed to see whether 
abnormalities occurred in 1 or 2 nerves, as re- 
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Table 3. Sensitivity of 3 sets of electrodiagnostic criteria for primary demyelination for patients with the clinical diagnosis of CIDP, 
and specificity for patients with motor neuron disease and diabetic polyneuropathy. 
Sensitivity: True positive rate Set A Modified set A Set B Set C Modified set C 
Fulfilling all criteria 35/70 (50%) 46/70 (66%) 32/70 (46%) 30/70 (43%) 46/70 (66%) 
Fulfilling all criteria with sufficient nerves tested 35/55 (64%) 32/53 (60%) 30/62 (48%) 
Motor neuron disease 
Specificity: True negative rate Set A Set B 
~ 
Set C 
Fulfilling no criteria 47/47 (100%) 47/47 (1 00%) 47/47 (100%) 
Fulfilling no criteria with sufficient nerves tested 35/35 (1 00%) 1711 7 (1 00%) 17/17 (1 00%) 
Diabetic polyneuropathy 
Set A Set B Set C 
Fulfilling no criteria 63/63 (100%) 63/63 (1 00%) 63/63 (1 OOYo) 
Fulfilling no criteria with sufficient nerves tested 8/8 (1 OOYo) 10/10 (100%) 7/7 (1 00%) 
Table 4. Number of abnormalities in all motor nerves tested according to three sets of criteria for electrodiagnostic evidence for 
primary demyelination in patients with CIDP, motor neuron disease, and diabetic polyneuropathy. 
ClDP 
Set A Set B Set C 
Conduction velocity 
Distal latency 




Conduction blocklabnormal dispersion 
F-wave latency 
153/216 (71%) 110/216 (51%) 89/21 6 (39%) 
89/227 (39%) 82/227 (36%) 
98/210 (47%) 120/210 (57%) 
66/172 (38%) 111/172 (65%) 
Motor neuron disease 












Set A Set B Set C 
Conduction velocity 3105 (3%) 3105 (3%) 1/105 (1%) 
Conduction blocklabnormal dispersion 61103 (6%) 17/103 (1 7%) 
F-wave latency 0/89 (OYo) 8/91 (9%) 
Distal latency 4/156 (3%) 3/156 (2%) 
quired by each set (Table l),  the sensitivity of indi- monly fulfilled because it was required in 2 
vidual measures changed (Table 5 ) .  For example, 
conduction blocWabnorma1 temporal dispersion 
was the most commonly fulfilled measure, in part 
because only 1 nerve was required to be abnormal 
in both sets A and B. On the other hand, although 
F waves were frequently abnormal in individual 
nerves in set B, this abnormality was less com- 
nerves. 
Specificity of Criteria A, B, and C in Other Neuro- 
pathic Disorders. Specificity (true negative rate) 
of the 3 sets was tested with nerve conduction data 
from patients with MND and DP, and no patients 
fulfill any set for primary demyelination (Table 3). 
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Table 5. Relationship of abnormal values for electrodiagnostic criteria sets A, 8, and C. 
Percentage of CMAP Distal Conduction F-wave Proximal/ 
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Fewer nerves were tested than in patients with 
CIDP, but when consideration was given for suffi- 
cient numbers tested, only 1 patient with DP could 
possibly fulfill set C. 
Several differences in nerve conduction abnor- 
malities were noted between primary demyelinat- 
ing and primary axonal disorders (Table 4). First, 
abnormalities of conduction velocity, distal la- 
tency, and F-wave latency were uncommon in 
both MND and DP, but occurred frequently in 
CIDP. Second, conduction blocWabnorma1 tempo- 
ral dispersion was the most common abnormal 
measure in MND and DP, but occurs significantly 
less frequently in MND and DP than in CIDP (P 
< .0001 for each comparison). 
Analysis of Different Criteria. Sensitivity of elec- 
trodiagnostic criteria can be increased by 3 meth- 
ods. First, the required number of abnormal con- 
duction measures can be reduced. This method 
was used in set C (Table l), but sensitivity was only 
43% when abnormal conduction velocity was re- 
quired in 2 nerves (Table 3). When abnormal con- 
duction velocity was required in only 1 nerve 
(modified set C, Table l), sensitivity increased to 
66% (Table 3). 
Second, all nerve conduction measures can be 
evaluated, but each given equal weight so that an 
abnormal measure in 1 nerve can be used to fulfill 
criterion. Using the abnormal values from set A, 
but modified, so that conduction velocity and dis- 
tal latency criteria were fulfilled when abnormal in 
only 1 nerve (modified set A, Table l ) ,  sensitivity 
increased to 6676, while specificity was unchanged 
at 100% (Table 3). 
Third, abnormal values for each nerve conduc- 
tion measure can be made less stringent, with a 
goal of achieving at least 75% sensitivity and 75% 
specificity for each measure. The distribution of 
nerve conduction values for each conduction mea- 
sure revealed substantial overlap among the 3 dis- 
orders and with the normal range (Fig. 1). Abnor- 
mal values, which include 75% of CIDP patients, 
were near the ULN and LLN for each measure, 
thereby potentially including normal subjects. 
The values marking the 75th percentile for 
sensitivity for CIDP patients were also values 
which include up to 59% of patients with MND 
and DP. When values at the 75th percentile for in- 
dividual nerve conduction measures were substi- 
tuted for the values in sets A and B, overall sensi- 
tivity for CIDP patients rose to nearly loo%, but 
specificity fell to nearly 0%. This increase in sensi- 
tivity and decrease in specificity was due to the 
fact that multiple nerves, each with values at 75% 
sensitivity and 75% specificity, were tested in an 
individual patient. Although many combinations 
can be chosen of abnormal values, and numbers 
of abnormal measures required to fulfill all crite- 
ria, 66% sensitivity appeared to be a practical limit 
attainable without reducing specificity. This level 
of sensitivity can be achieved by requiring only a 
single abnormality in 1 nerve (modified set C), or 
less stringent abnormalities in several nerves 
(modified set A). 
DISCUSSION 
Evaluation of 3 electrodiagnostic criteria for estab- 
lishing the diagnosis of demyelinating polyneur- 
opathy indicates that sets A and B have similar 
sensitivity. The greater complexity of set B, based 
on the amplitude of the distal CMAP, does not ap- 
pear to offer an advantage. This is found to occur 
for several reasons. The distal CMAP amplitude is 
below 80% of the LLN in 38% of tested nerves, 
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Table 6. Number of patients fulfilling individual nerve conduction criterions for electrodiagnostic evidence for primary demyelination. 
CIDP 
Set A Set B Set C 
Conduction velocity (2 nerves) 37/70 (53%) 38/70 (54%) 30170 (43%) 
Distal latency (2 nerves) 29/70 (41 Yo) 27/70 (39%) 
Conduction blocklabnormal dispersion (1 nerve) 59/70 (84%) 64/70 (91 %) 
F-wave latency (set A 1 nerve, set B 2 nerves) 38/70 (54%) 34/70 (49%) 
Motor neuron disease 
Set A Set 6 Set C 
Conduction velocity (2 nerves) 0147 (OD/) 0147 (0%) 0147 (0%) 
Distal latency (2 nerves) 0147 (0%) 0147 (0%) 
Conduction blocklabnormal dispersion (1 nerve) 11/47 (23%) 17/47 (36%) 
F-wave latency (set A 1 nerve, set 6 2 nerves) 0147 (0%) 0/47 (0%) 
Diabetic polvneuropathv 
Set A Set B Set C 
0163 (0%) Conduction velocity (2 nerves) 0/63 (0%) 1/63 (2%) 
Distal latency (2 nerves) 0163 (0%) 0/63 (0%) 
F-wave latency (set A 1 nerve, set B 2 nerves) 0163 (0%) 0163 (0%) 
Conduction blocklabnormal dispersion (1 nerve) 6/63 (10%) 16/63 (25%) 
and for the majority of nerves, therefore, the ab- 
normal values in set B are less stringent than those 
in set A in this group of CIDP patients (Table 5). 
However, the 2 sets of values are sufficiently simi- 
lar to include nearly equal percentages of patients 
for each measure (Table 6) .  Set B requires abnor- 
mal F waves in 2 nerves, but permits the absence 
of an F wave after a suitable number of trials to 
count toward fulfillment (Table 1). Although set A 
does not count an absent F wave as abnormal, it 
requires only one abnormal response, which re- 
sults in no significant differences in the propor- 
tion of patients fulfilling this measure in sets A 
and B. 
Increasing the sensitivity of the criteria proved 
difficult. While it is possible to calculate abnormal 
values which achieve 75% sensitivity for individual 
measures for CIDP patients, these values overlap 
conduction values from normal subjects and pa- 
tients with primary axonal loss (Fig. l). Substitu- 
tion of these calculated abnormal values in sets A 
and B results in nearly 100% sensitivity, but much 
lower specificity with false inclusion of nearly 
100% of patients with MND and DP. 
Although the 3 criteria require a specific num- 
ber of abnormal measures to achieve fulfillment, 
none addresses the question of how many motor 
nerves should be tested. There is a practical limit 
to the number of motor nerves accessible for test- 
ing, commonly the ulnar, median, peroneal, and 
tibia1 nerves. Bilateral measures of nerve conduc- 
tion from the same nerve are highly correlated in 
normal subjects and in CIDP patients (Bromberg, 
unpublished observations). Accordingly, to insure 
independent assessments, it is prudent to include 
data for a particular nerve from only 1 side of the 
body. 
When nerves are unresponsive to electrical 
stimulation, they do not contribute to any criteria, 
but only 15% of nerves tested are unresponsive in 
this sample of CIDP patients. Although a number 
of patients fulfill criteria for primary demyelina- 
tion when only 2 nerves are tested, it is reasonable 
to require testing of 4 motor nerve before con- 
cluding that a patient does not meet the criteria, 
with notation of the number of unresponsive 
nerves. In the same vein, an F-wave response 
should be considered absent only after a suitable 
number of trials, as required in set B. 
It is difficult to compare the 48% to 66% sensi- 
tivity obtained in this sample of CIDP patients to 
other samples. Early studies relied on slowed con- 
duction velocity only, and conduction data are fre- 
quently expressed in terms of group means.' ' , 20  
In  one series, only 67% of CIDP patients had 
slowed conduction velocity in a single motor 
nerve,4 and, in the current study group, 66% of 
patients fulfill this minimal requirement. 
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There are several reasons why sensitivity is not 
higher. Patients received their initial nerve con- 
duction study at different stages in the course of 
their disease. l 1  The extent of demyelination and 
remyelination during the course of the polyneur- 
opathy affects nerve conduction. In acute inflam- 
matory demyelinating polyradiculoneuropathy 
(AIDP), which has a monophasic time course of 
demyelination, up  to 86% of patients fulfill a sim- 
ilar set of electrodiagnostic criteria at the peak of 
symptoms, but only 63% to 67% fulfill criteria 
during the early convalescent phase.2 This is a 
similar percentage to that seen in CIDP using the 
AIDP  riter ria.^ Another factor is that the only 
commonly available measure of conduction over 
proximal nerve segments, where demyelination 
may be severe, is F wave latency. l 1  
Partial conduction blocldabnormal temporal 
dispersion is a sensitive measure for detecting pri- 
mary demyelination, and may occur to a reater 
degree in more proximal nerve segments!17 Re- 
cording responses over more proximal segments 
may be one method of increasing the likelihood of 
detecting this abnormality. This can be performed 
practically along the ulnar nerve by stimulating 
below and above the elbow, at the mid-arm, at the 
axilla, and at Erb's point.' 
There are no false positive errors for the three 
criteria. DP was chosen as a difficult test of the cri- 
teria. Although pathological changes support ax- 
onal degeneration as the primary process and de- 
myelination as a lesser process,6 electrodiagnostic 
features of DP include reduced CMAP amplitude, 
prolonged distal and F-wave latencies, and slowed 
conduction velocity. lo Specificity has also been 
demonstrated by the diagnosis of CIDP superim- 
posed on DP when nerve conduction studies fulfill 
criteria for primary demyelination.8 All diabetic 
patients had symptomatic polyneuropathy of mild 
to moderate degree; all but 2 had abnormal spon- 
taneous activity on needle electromyography, and 
many had absent evoked motor and sensory nerve 
responses. 
MND was chosen because it is a motor neuron- 
opathy with reduced CMAP, mildly prolonged di- 
stal latency, and slowed conduction velocity, pre- 
sumably secondary to loss of large motor  fiber^.^ 
The only abnormal measure encountered is con- 
duction blocMabnormal temporal dispersion. Ap- 
parent conduction block can occur when there are 
few motor fibers remaining, and the motor units 
are enlarged; in this situation, normal temporal 
dispersion can reduce phase addition in the re- 
sponse recorded after stimulation at proximal 
sites.' Ten of 12 nerves showing block in patients 
with MND have low CMAP amplitude, and likely 
demonstrate apparent conduction block by this 
mechanism. Attention to conduction block is im- 
portant because true conduction block may be the 
first diagnostic clue to a special form of multifocal 
demyelinating motor neuropathy which mimics 
clinical features of MND, but which is potentially 
treatable. 15,19 
In summary, the criteria currently proposed 
for demonstrating electrodiagnostic evidence for 
primary demyelination, while highly specific, are 
only moderately sensitive. With few changes in 
these criteria, the maximal sensitivity with ade- 
quate specificity appears to be about 66%. This 
can be achieved by requiring a single abnormal 
measure (conduction velocity) in 1 nerve (modi- 
fied set C ) ,  or by requiring several different ab- 
normal conduction measures (modified set A). 
There are arguments favoring use of criteria, 
which require greater numbers of abnormalities. 
First, they increase diagnostic confidence by ex- 
cluding forms of hereditary neuropathies and fo- 
cal entrapment neuropathies. Hereditary motor 
sensory neuropathy (type I) would commonly sat- 
isfy individual measures of distal latency, conduc- 
tion velocity, and F-wave latency, but not abnor- 
mal conduction blocldabnormal temporal 
d i s p e r s i ~ n . ' ~ , ' ~  A focal entrapment neuropathy 
could cause slow nerve conduction. Second, crite- 
ria requiring greater numbers of nerve abnormal- 
ities permit more detailed analysis of the effects of 
therapy. For example, reduction of conduction 
block or abnormal temporal dispersion, and im- 
provement in distal latency, may occur before im- 
provement in conduction velocity during ther- 
apy," and this would be missed if only the latter 
were being monitored. 
Third, nerve conduction studies, as routinely 
applied to distal limb segments, may underesti- 
mate the extent of the demyelinating process." 
Since conduction blocldabnormal temporal disper- 
sion is a frequently abnormal measure, more ex- 
tensive testing for this abnormality may increase 
sensitivity. 
Although nerve conduction abnormalities in 
CIDP appear to be distinct from those in neuro- 
pathic disorders without primary demyelination, 
the correct diagnosis of CIDP must rely upon as- 
sessment of all clinical data, and use of a full set of 
clinical and laboratory inclusion criteria, such as 
recently proposed lg4 will be helpful. 
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